How Big Pharma Drives Up Medicare Spending Without Improving Seniors’ Health

How Big Pharma Drives Up Medicare Spending Without Improving Seniors’ Health: The Medicare Part D prescription drug program for seniors wasted $1.4 billion paying for brand name drugs that were no more effective than their cheaper, generic counterparts, according to a new study by the Veterans Affairs Pittsburgh Healthcare System. That excess spending was driven in large part by pharmaceutical companies’ efforts to delay generic drug [...]/p